🇺🇸 FDA
Patent

US 11939317

Amide compounds and method for making and using

granted A61PA61P1/00A61P11/00

Quick answer

US patent 11939317 (Amide compounds and method for making and using) held by Rigel Pharmaceuticals, Inc. expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P1/00, A61P11/00, A61P25/00, A61P29/00